Medidata Solutions Inc (NASDAQ:MDSO) – Jefferies Financial Group reduced their Q2 2019 earnings per share (EPS) estimates for Medidata Solutions in a note issued to investors on Wednesday, May 1st. Jefferies Financial Group analyst D. Windley now expects that the company will post earnings of $0.15 per share for the quarter, down from their prior forecast of $0.17. Jefferies Financial Group also issued estimates for Medidata Solutions’ Q4 2019 earnings at $0.26 EPS and FY2020 earnings at $1.21 EPS.
A number of other brokerages also recently commented on MDSO. BidaskClub downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a report on Monday, January 7th. Zacks Investment Research downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a report on Monday, February 11th. Dougherty & Co downgraded shares of Medidata Solutions from a “buy” rating to a “neutral” rating in a report on Wednesday. TheStreet raised shares of Medidata Solutions from a “c+” rating to a “b-” rating in a research note on Friday, March 15th. Finally, Wells Fargo & Co downgraded shares of Medidata Solutions from an “outperform” rating to a “market perform” rating and set a $90.00 price objective for the company. in a research note on Tuesday, April 23rd. Two analysts have rated the stock with a sell rating, seven have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Medidata Solutions presently has a consensus rating of “Hold” and an average target price of $84.60.
Shares of NASDAQ:MDSO traded up $1.49 during trading on Friday, reaching $93.97. The company’s stock had a trading volume of 734,058 shares, compared to its average volume of 1,156,969. The company has a current ratio of 2.57, a quick ratio of 2.71 and a debt-to-equity ratio of 0.14. Medidata Solutions has a 12 month low of $60.10 and a 12 month high of $98.60. The company has a market cap of $5.85 billion, a price-to-earnings ratio of 97.89, a PEG ratio of 8.33 and a beta of 1.42.
Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.45 EPS for the quarter, beating the Zacks’ consensus estimate of $0.12 by $0.33. Medidata Solutions had a net margin of 7.99% and a return on equity of 9.28%. The firm had revenue of $173.50 million during the quarter, compared to the consensus estimate of $172.12 million. During the same quarter last year, the firm earned $0.40 EPS. The firm’s revenue for the quarter was up 16.3% compared to the same quarter last year.
In other news, EVP Michael Pray sold 15,000 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $76.50, for a total transaction of $1,147,500.00. Following the transaction, the executive vice president now directly owns 77,134 shares of the company’s stock, valued at $5,900,751. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Rouven Bergmann sold 12,512 shares of the firm’s stock in a transaction that occurred on Wednesday, February 6th. The stock was sold at an average price of $75.00, for a total transaction of $938,400.00. The disclosure for this sale can be found here. In the last three months, insiders sold 47,237 shares of company stock valued at $3,568,628. 4.70% of the stock is owned by insiders.
Several large investors have recently modified their holdings of MDSO. Dimensional Fund Advisors LP increased its position in shares of Medidata Solutions by 6.9% during the third quarter. Dimensional Fund Advisors LP now owns 143,913 shares of the company’s stock worth $10,551,000 after acquiring an additional 9,333 shares during the period. LPL Financial LLC increased its position in shares of Medidata Solutions by 25.2% during the third quarter. LPL Financial LLC now owns 15,840 shares of the company’s stock worth $1,161,000 after acquiring an additional 3,185 shares during the period. Man Group plc purchased a new position in shares of Medidata Solutions during the third quarter worth approximately $205,000. Thrivent Financial for Lutherans increased its position in shares of Medidata Solutions by 5.8% during the third quarter. Thrivent Financial for Lutherans now owns 14,280 shares of the company’s stock worth $1,047,000 after acquiring an additional 787 shares during the period. Finally, Macquarie Group Ltd. increased its position in shares of Medidata Solutions by 7.0% during the third quarter. Macquarie Group Ltd. now owns 24,834 shares of the company’s stock worth $1,821,000 after acquiring an additional 1,616 shares during the period.
Medidata Solutions Company Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.
Featured Article: Green Investing